Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TransMedics Group Inc (TMDX) vs YieldMax TSLA Option Income Strategy ETF (TSLY) Price & Performance

TransMedics Group IncTrade
YieldMax TSLA Option Income Strategy ETFTrade

Price performance (Past 24H)

Key statistics

TransMedics Group Inc vs YieldMax TSLA Option Income Strategy ETF — how do they compare? TransMedics Group Inc trades at $77.75 (market cap $2.74B), while YieldMax TSLA Option Income Strategy ETF trades at $22.47 (market cap $697.51M). The key difference: TransMedics Group Inc is far larger — about 3.9× YieldMax TSLA Option Income Strategy ETF's market cap, and TransMedics Group Inc is more actively traded (949,331 versus 338,271). Which is the better fit depends on your goals — on Pluang, investors hold TransMedics Group Inc for 24 Days and YieldMax TSLA Option Income Strategy ETF for 43 Days on average.

TMDXTSLY
Market Cap
$2.74B$697.51M
Volume
949,331338,271
Sector
HealthIncome / Options Overlay
52-Week High
$150.42$43.35
52-Week Low
$61.99$20.49
Typical Hold Time
24 Days43 Days
Enterprise Value
$3.13B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

TransMedics Group Inc

TransMedics Group (TMDX) trades at $80.69, down 0.47% on the day, amid a bearish technical signal and mixed earnings performance. The company reported strong revenue growth to $605.49M in 2025 with a net income margin of 22.69%, but recent quarters have seen earnings misses. Analyst sentiment remains positive with a consensus price target of $99.75 and a 69% buy rating, though news flow includes investigations into fiduciary duties.

The outlook balances robust fundamentals against near-term headwinds. Upside potential exists from the high analyst target and strong profitability metrics like a 36.28% ROE, but risks include earnings volatility, margin pressure, and ongoing legal scrutiny. The stock's current valuation at a P/E of 20.47 offers a reasonable entry if execution improves.

YieldMax TSLA Option Income Strategy ETF

TSLY trades at $22.60, down 0.44% with a bullish technical signal supported by moving averages. The ETF maintains consistent weekly dividend distributions averaging $0.21-0.23, though recent analysis highlights concerns about capital erosion despite high yields. Technical indicators show support at $22 and resistance at $23, with neutral oscillators suggesting limited momentum.

While TSLY offers attractive income generation through its option income strategy, the fund faces structural limitations in capturing Tesla's upside potential. Recent downgrades to Hold reflect diminished return prospects amid Tesla's volatility changes. The primary risk remains the trade-off between high distributions and long-term capital preservation.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TMDX
100% Buy0% Sell
Avg holding period · 24 Days
TSLY
38% Buy62% Sell
Avg holding period · 43 Days

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX →

About YieldMax TSLA Option Income Strategy ETF

TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.

Read more on TSLY →